Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CRAIG J VINE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1164400495
CMS profile
7469
Location
ST PAUL, MN

General Payments · PY2018–2024

$171,241.03

  • Reported across 362 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$16,505.20

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alkermes, Inc. $8,154.42 8
Neurocrine BioSciences, Inc. $7,882.16 14
Neuronetics, Inc. $155.95 1
LivaNova USA, Inc. $117.19 1
Tempus AI, Inc $114.46 2
ITI, Inc. $19.50 1
Lundbeck LLC $17.55 1
Takeda Pharmaceuticals U.S.A., Inc. $15.48 1
Vanda Pharmaceuticals Inc. $15.46 1
Corium, Inc. $13.03 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $35,329.43 84
PY2019 $30,992.95 90
PY2020 $3,328.75 15
PY2021 $10,937.23 27
PY2022 $39,605.59 70
PY2023 $34,541.88 45
PY2024 $16,505.20 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $7.37 02/14/2024 Food and Beverage Undisputed 01/23/2026 1120614938 CMS
Alkermes, Inc. $396.19 06/08/2024 Travel and Lodging Undisputed 01/23/2026 1120614940 CMS
Alkermes, Inc. $303.97 06/08/2024 Travel and Lodging Undisputed 01/23/2026 1120614942 CMS
Alkermes, Inc. $5,430.00 07/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1120614944 CMS
Alkermes, Inc. $41.06 07/08/2024 Travel and Lodging Undisputed 01/23/2026 1120614946 CMS
Alkermes, Inc. $33.00 07/08/2024 Travel and Lodging Undisputed 01/23/2026 1120614948 CMS
Alkermes, Inc. $1,910.00 08/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1120614950 CMS
Alkermes, Inc. $32.83 08/21/2024 Travel and Lodging Undisputed 01/23/2026 1120614952 CMS
Corium, LLC $13.03 06/20/2024 Food and Beverage Undisputed 01/23/2026 1100117362 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.50 04/30/2024 Food and Beverage Undisputed 01/23/2026 1143339445 CMS
LivaNova USA, Inc. $117.19 02/22/2024 Food and Beverage Undisputed 01/23/2026 1152789607 CMS
Lundbeck LLC $17.55 12/10/2024 Food and Beverage Undisputed 01/23/2026 1145978677 CMS
Neurocrine Biosciences, Inc. $124.99 03/01/2024 Food and Beverage Undisputed 01/23/2026 1150809052 CMS
Neurocrine Biosciences, Inc. $51.92 03/02/2024 Food and Beverage Undisputed 01/23/2026 1150813862 CMS
Neurocrine Biosciences, Inc. $43.27 03/02/2024 Food and Beverage Undisputed 01/23/2026 1150814590 CMS
Neurocrine Biosciences, Inc. $474.21 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1150815466 CMS
Neurocrine Biosciences, Inc. $28.85 03/02/2024 Food and Beverage Undisputed 01/23/2026 1150828598 CMS
Neurocrine Biosciences, Inc. $24.01 03/02/2024 Food and Beverage Undisputed 01/23/2026 1150842988 CMS
Neurocrine Biosciences, Inc. $175.56 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1150848232 CMS
Neurocrine Biosciences, Inc. $14.40 03/02/2024 Food and Beverage Undisputed 01/23/2026 1150876620 CMS
Neurocrine Biosciences, Inc. $6,750.00 03/19/2024 Consulting Fee Undisputed 01/23/2026 1150807057 CMS
Neurocrine Biosciences, Inc. $35.00 03/21/2024 Travel and Lodging Undisputed 01/23/2026 1150874672 CMS
Neurocrine Biosciences, Inc. $25.06 03/21/2024 Travel and Lodging Undisputed 01/23/2026 1150880639 CMS
Neurocrine Biosciences, Inc. $89.94 03/29/2024 Travel and Lodging Undisputed 01/23/2026 1150856714 CMS
Neurocrine Biosciences, Inc. $34.05 03/29/2024 Travel and Lodging Undisputed 01/23/2026 1150874750 CMS
Neurocrine Biosciences, Inc. $10.90 07/16/2024 Food and Beverage Undisputed 01/23/2026 1150881843 CMS
Neuronetics, Inc. $155.95 07/31/2024 Food and Beverage Undisputed 01/23/2026 1073309178 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.48 09/04/2024 Food and Beverage Undisputed 01/23/2026 1137692936 CMS
Tempus AI, Inc $88.70 12/04/2024 Food and Beverage Undisputed 01/23/2026 1150176589 CMS
Tempus AI, Inc $25.76 12/12/2024 Food and Beverage Undisputed 01/23/2026 1150176591 CMS
Vanda Pharmaceuticals Inc. $15.46 07/23/2024 Food and Beverage Undisputed 01/23/2026 1133925280 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.